Quark Biotech generates a cholesterol-free mouse

Fremont, CA - December 18, 2003 - Quark Biotech, Inc. (QBI) today announced the publication in the prestigious peer reviewed scientific journal, Science, the results of a study of mice that contain virtually no cholesterol. The study was conducted together with scientists from the Karolinska Institute in Sweden and the Sackler School of Medicine in Israel. This mouse strain was created by disrupting the gene Dhcr24, which encodes the enzyme called desmosterol reductase and appears to be responsible for the last step in the biosynthesis of cholesterol, a sterol that is an indispensable structural block of cells and their membranes and plays major roles in signal transduction. The paper entitled "Generation of Viable Cholesterol-Free Mice," appears in Science, December 19, 2003 (Vol. 302, Page 2087).

"We were surprised by the fact that a mouse lacking cholesterol can survive and develop into adulthood with little effect, when cholesterol accounts for approximately 99% of all steroids in mammals," commented Dr. Elena Feinstein, VP of Technology Development at Quark Biotech and senior author of the study. "We believe that this mouse can become a highly resourceful tool to further understand the role of cholesterol in the different organs. This knowledge can in the future help discover novel drugs and understand the mechanism of action of existing drugs for metabolic diseases and cancer, among others."

The study supports for the first time in a complex organisms model the "sterol synergism" theory, which points out the interchangeability of certain sterols, that up to now had only been shown in simple models such as yeast. However, the research conducted suggests the importance of cholesterol in the developmental stages, particularly during embryogenesis. Furthermore, the knock-out pups appeared to be smaller in size and showed poorer growth characteristics than the normal animals.

Dr. Daniel Zurr, CEO of Quark Biotech said, "Quark initiat

Contact: Wendy Lau
Euro RSCG Life NRP

Page: 1 2

Related biology news :

1. Can you tell the difference between Quarks and DNA?
2. Nanosphere announces genetic detection advance in Nature Biotechnology
3. Leroy Hood to receive 2004 Biotechnology Heritage Award
4. Christopher Walsh wins 2004 Promega Biotechnology Research Award
5. Advancing Biotechnology Breakthroughs
6. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
7. Army awards up to $50 million to establish Institute for Collaborative Biotechnologies
8. US-EC Biotech Task Force keys on research, collaboration
9. Chemical Heritage Foundation and BIO give Biotechnology Heritage Award to William Rutter
10. Biotechnology taught as a tool for teaching
11. Biotech regulations impede crop domestication

Post Your Comments:

(Date:7/4/2020)... ... July 03, 2020 , ... ... earn outstanding recognition and multiple awards for not only the products and treatments ... SoME® Skincare and Vivace® Microneedle RF. All the brands built by ABM have ...
(Date:6/28/2020)... , ... June 25, 2020 ... ... enterprise software solutions for biopharmaceutical R&D, today announced that it has entered ... innovative, full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research ...
(Date:6/23/2020)... ... ... The field of quantitation of large molecules or proteins has been around for a ... of mass spectrometry in this field has gained a lot of momentum in the ... approach to use (LBA or MS)?” In many cases, either technology can answer ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... LEXINGTON, Mass. (PRWEB) , ... July 09, 2020 ... ... novel approaches to cell therapy, today announced the hiring of Allen R. Nissenson, ... executive team and oversee the clinical development of Sentien’s lead product, SBI-101. ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... that the launch of a new clinical diagnostics immuno-oncology service, TissueInsight ... microenvironment (TME). , “Flagship’s TissueInsight is a service that aids pathologists, oncologists, ...
(Date:6/23/2020)... ... , ... Kerafast Inc. , developers of an online ... of the Delta-G-VSV Pseudotyping System for coronavirus research applications. The system, developed by ... entry and COVID-19 vaccine effectiveness at just biosafety level 2 (BSL-2) containment. , ...
(Date:6/19/2020)... (PRWEB) , ... June 18, 2020 , ... The ... Its goal is to join forces to radically prolong life and find a way ... the aging period. This project was supported by various scientists from all over the ...
Breaking Biology Technology:
Cached News: